Nearly 500 million adults worldwide are living with type 2 diabetes, and over 200 million of them take metformin, a common medication that helps lower...
Vous n'êtes pas connecté
Rosiglitazone is a drug used to treat type 2 diabetes, a condition where the body struggles to manage blood sugar levels. Belonging to a class of drugs called thiazolidinediones, it was once considered a promising new option for people with type 2 diabetes. However, recent research from the Yale School of Public Health has uncovered […]
Nearly 500 million adults worldwide are living with type 2 diabetes, and over 200 million of them take metformin, a common medication that helps lower...
Researchers from the University of Missouri have found that an FDA-approved drug used to lower blood sugar in adults with type 2 diabetes may also...
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
A recent study from the University of Toronto has found that eating nuts instead of carbohydrates may help people with type 2 diabetes manage their...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to manage diabetes, have recently been linked to a rare but serious...
New research has shown that low levels of lipoprotein(a), a type of fat and protein in the blood, do not cause type 2 diabetes. This finding might...
learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes
learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes